Carsten S. Kramer

Wiesbaden, HE 65191, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3.

Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 11, 2025

The Influence of Radioligand Therapy on Immunogenicity Against SARS-CoV-2-A Retrospective Single-Arm Cohort Study of Metastatic Prostate Cancer Patients Receiving PSMA Radioligand Therapy.

The Influence of Radioligand Therapy on Immunogenicity Against SARS-CoV-2-A Retrospective Single-Arm Cohort Study of Metastatic Prostate Cancer Patients Receiving PSMA Radioligand Therapy.

Journal: Cancers

Published: February 27, 2025

Extraordinary therapeutic effect of PSMA radioligand therapy in treatment-refractory progressive metastatic prostate cancer with the transketolase inhibitor benfo-oxythiamine as a radiosensitizer-A case report.

Extraordinary therapeutic effect of PSMA radioligand therapy in treatment-refractory progressive metastatic prostate cancer with the transketolase inhibitor benfo-oxythiamine as a radiosensitizer-A case report.

Journal: Frontiers in medicine

Published: July 09, 2024

Efforts toward PET-Activatable Red-Shifted Silicon Rhodamines and Silicon Pyronine Dyes.

Efforts toward PET-Activatable Red-Shifted Silicon Rhodamines and Silicon Pyronine Dyes.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 08, 2023

From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [68Ga]Ga-DATA5m.SA.FAPi.

From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [68Ga]Ga-DATA5m.SA.FAPi.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 30, 2022

Immuno-Imaging (PET/SPECT)-Quo Vadis?

Immuno-Imaging (PET/SPECT)-Quo Vadis?

Journal: Molecules (Basel, Switzerland)

Published: December 04, 2021

Fluorination of silyl prosthetic groups by fluorine mediated silyl ether linker cleavage: a concept study with conditions applicable in radiofluorination.

Fluorination of silyl prosthetic groups by fluorine mediated silyl ether linker cleavage: a concept study with conditions applicable in radiofluorination.

Journal: EJNMMI radiopharmacy and chemistry

Published: October 15, 2021

Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents.

Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 21, 2021

Rhenium and technetium-complexed silicon rhodamines as near-infrared imaging probes for bimodal SPECT- and optical imaging.

Rhenium and technetium-complexed silicon rhodamines as near-infrared imaging probes for bimodal SPECT- and optical imaging.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: May 15, 2020

Synthesis of a dihalogenated pyridinyl silicon rhodamine for mitochondrial imaging by a halogen dance rearrangement.

Synthesis of a dihalogenated pyridinyl silicon rhodamine for mitochondrial imaging by a halogen dance rearrangement.

Journal: Beilstein journal of organic chemistry

Published: May 31, 2019

A new approach to silicon rhodamines by Suzuki-Miyaura coupling - scope and limitations.

A new approach to silicon rhodamines by Suzuki-Miyaura coupling - scope and limitations.

Journal: Beilstein journal of organic chemistry

Published: May 31, 2019

Search for Subsolar Mass Ultracompact Binaries in Advanced LIGO's Second Observing Run.

Search for Subsolar Mass Ultracompact Binaries in Advanced LIGO's Second Observing Run.

Journal: Physical review letters

Published: May 25, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026